Tumourigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumour mechanism. by Jacubovich, R. et al.
Br. J. Cancer (1985), 51, 335-345
Tumourigenic phenotypes of human melanoma cell lines in
nude mice determined by an active antitumour mechanism
R. Jacubovich, H. Cabrillat, D. Gerlier, M. Bailly & J.F. Dore
Inserum U. 218, Centre Leon Berard, 69373 Lyon Cedex 2, France.
Summary Ten human melanoma cell lines (HMCL) were tested for their ability to grow subcutaneously in
nude mice. Using a standard inoculum, the HMCL could be characterized by their highly, fairly or poorly
xenografting phenotype. These phenotypes were stable and the phenotype of one HMCL was recovered
within cell clones derived from it. The role of nude mice natural defences in the expression of HMCL
xenografting phenotypes was studied. Sublethal whole body irradiation and silica pretreatment of recipients
enabled poorly tumourigenic HMCL to grow in most animals without affecting their splenic NK activity.
Admixture of BCG or MDP encapsulated in liposomes with highly tumourigenic HMCL resulted in the
abrogation of tumour growth in naive nude mice. The long lasting abrogating of NK activity in vivo by
treatment with anti-asialo-GM1 anti-serum did not enhance the growth of a poorly tumourigenic HMCL. The
HMCL were found to be resistant to in vitro murine NK activity. These results showed that the expression of
the HMCL xenografting phenotypes could be controlled by the nude mice natural defences. NK cells did not
seem to be largely involved whereas macrophages might be good candidates as anti-xenograft effectors.
There have been numerous reports of the successful
transplantation of both primary and tissue culture-
passaged xenogeneic tumour cell lines into
congenitally athymic (nude) mice (Fogh et al., 1977;
Gershwin et al., 1977; Giovanella et al., 1978).
Initially, tumourigenicity in the nude mouse has
been claimed to be a major characteristic of
malignancy for primary or cultured tumour cells
(Stiles et al., 1976). However, some human
malignant cells fail to grow in the nude mouse;
among these are breast carcinoma cells (Sebesteny
et al., 1979), prostatic carcinoma cells (Reid et al.,
1978) and haemopoietic cell lines (Epstein et al.,
1976; White et al., 1984). Here, it might be
questioned whether the xenografting ability might
reflect particular properties of the malignant cells in
an in vivo environment. Numerous explanations,
including substrate, local nutritional, vascular,
endocrine and individual tumour specific
requirements, have been proposed for the failure of
some tumour lines to grow on hetero-
transplantation (Reid et al., 1979; Walker et al.,
1980). In addition, nude mice appear not to be
totally immunodeficient; they do not have a higher
incidence of spontaneous tumours than normal
mice, are not more susceptible to chemical
carcinogenesis (Stutman, 1978) and show infrequent
metastases of tumours known to be metastatic in
their original host (Sharkey & Fogh, 1979). The
transplantation success rate of tumour growth can
be enhanced by using newborn, X-irradiated or
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antilymphocyte serum-treated nude mice (Ohsugi et
al., 1980), or congenitally athymic asplenic (Lasat)
mice (Gershwin et al., 1978). Thus, it has been
suggested that an active rejection mechanism such
as natural immunity may hamper the growth of
heterologous tumour cells in nude mice (Minato et
al., 1979).
The present studies were initiated to develop an
appropriate model system for defining the
xenografting phenotype of 10 human melanoma cell
lines (HMCL) and for studying the possible role of
the natural immunity in the tumour rejection of
these cell lines by the nude mice. Using standard
conditions, i.e. the same inoculum of cells, HMCL
could be characterized by their xenografting
phenotype which varied from highly to poorly
tumourigenic, despite the fact that each of these cell
lines expressed other characteristics of malignancy.
Xenograft experiments in nude mice treated with
agents known to depress or to stimulate natural
immunity indicated that active mechanisms may be
involved in the growth control of the xenogenic
tumour cell lines. A major role of NI cells in
xenograft rejection was not found which confirmed
our preliminary results (Jacubovich et al., 1984).
Data are also presented here which indicated that
macrophages may be involved in the xenograft
rejection.
Materials and methods
Animals and tumour
Six weeks week-old male outbred Swiss nu/nu mice
were purchased from IFFA-CREDO (France).
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Bedding material was sterilized before use and the
cages were covered by an air filter (Isocap, Iffa-
Credo, France). Ten HMCL were maintained as
monolayers in RPMI 1629 tissue culture medium,
supplemented with 10% foetal calf serum, 2mM L-
glutamine, 100IU/ml-1 penicillin and 50pgml-
streptomycin. MlDo, M2Ge, M3Dau and M4Beu
were originally derived in our laboratory from
metastatic tumours and have been previously
characterized (Jacubovich & Dore, 1979). Ten
clones (named MlDoc or MlDoc R) were obtained
by limiting dilution from the MIDo cell line. Mel 8,
14, 17, 21, 34 and BII cell line also derived from
metastatic tumours were generously provided by E.
Leftheriotis and H. Peter, respectively. All these
tumour cell lines were free from mycoplasma using
the [3H]-Uridine/[3H]-Uracil incorporation test
(Schneider et al., 1974). For heterotransplantation
in nude mice, melanoma cells were trypsinized
(0.25%) in the presence of EDTA from confluent
monolayers. After 3 washes in PBS pH 7.5, the
cells were resuspended at 20 x 106 viable cells ml-1.
The mouse tumour cell line YAC 1 (a kind gift
from A. Senik) was maintained in RPMI 1640
culture medium supplemented with 10% foetal calf
serum, 2mM L-glutamine, antibiotics, 5mM
HEPES and 5 x 10 5M f -2 mercaptoethanol.
Tumour transplantation
Viable tumour cells (0.5, 1 or 2 x 106 in 0.1 ml) were
inoculated s.c. on the belly of nude mice. Tumour
growth rate was determined by weekly measure of
two perpendicular diameters of the tumour for 7
weeks. Tumours showed encapsulated growth.
Local or distant metastases were never observed.
Electronmicroscopy studies of nude mouse tumours
and of cells recultured from tumours showed
ultrastructural characteristics of melanocytes.
Karyotypes of cells recultured from nude mouse
tumours have been shown to be human and to have
retained marker chromosomes characterizing the
HMCL prior to heterotransplantation (Bertrand et
al., 1984).
Nude mice treatments
Irradiation The mice were sublethally irradiated
with 4.5Gy of 60Co y-irradiation or 3.61 Gy from a
200kV X-ray source 24h prior to tumour cell
grafting.
Silica treatment Five mg of sterilized silica
particles (95% <5j, kindly provided by D.
Lebouffant) were injected i.p. as 0.5ml PBS
solution in the nude mice, 4h before HMCL
inoculation.
Antiasialo GM1 treatment Rabbit antiasialo GM1
serum was a generous gift from M. Iwamori. This
antiserum (1:100) could abrogate NK activity in
vitro from nude spleen cells in the presence of
guinea pig complement (1:10). After filtration
through 0.22,p filter, 100l of the antiserum diluted
1:10 were injected i.v. in the tail vein, 18h before
heterotransplantation. As controls, some animals
were treated with normal rabbit serum.
Local treatment In some experiments, 100 or
500pg of Immuno-BCG (Institut Pasteur, France)
were admixed with the tumour cell inoculum just
before the s.c. injection. As controls, 2 x 106 tumour
cells were also incubated in vitro with 500,ug of
BCG at 37°C. No adverse effect of mycobacteria
was seen on the melanoma cells even after 48h of
culture. In other experiments, multilamellar
liposomes containing- nuramyl dipeptide (MDP)
were injected together with the tumour cell
inoculum. Multilamellar liposomes were prepared
as previously described (Gerlier et al., 1983).
Briefly, a film of distearoylphospha-
tidylcholine (Sigma Co., St Louis) and L-a-
phosphatidylserine (Sigma Co., St Louis) in 7:3
molar ratio was dispersed in 1 mgml-1 myramyl
dipeptide (Interchim, Montluqon, France) in PBS at
56°C for 2min. After 3 washes, the liposomes were
pelleted at 20,000rpm for 20min and resuspended
at around 20pmol of phospholipids ml-1 in PBS.
The amount of MDP entrapped in liposomes was
estimated from aqueous volume determination
using 5,6-carboxyfluorescein as a probe (Bakouche
& Gerlier, 1983). Empty liposomes were similarly
prepared using PBS instead of the MDP solution.
NK cytotoxicity assay
NK activity in spleen cells from untreated or
treated nude mice was determined using a 5"Cr
release test with YAC-1 tumour cells as tragets.
Briefly, the spleen was perfused with PBS and
minced. After 3 washes, the cells were resuspended
at 107 cellsml-1. In some experiments, spleen cells
were passed through a nylon wool column and the
cytotoxic activity of non adherent and adherent
cells (recovered after mechanical dispersion of the
nylon wool in cold medium) was tested (Julius et
al., 1973). Alternatively, 50 x 106 spleen cells in
complete medium were depleted from plastic
adherent cells after incubation for 2h at 37°C in
,93 mm3 Petri dishes.
For the cytotoxicity assay, 5 x 106 YAC-l cells
were labelled with 100pCi of Na51CrO4
(480pCi g-1 Cr, NEN, Boston, MA). After 3
washes, 104 labelled YAC-1 cells in 0.2ml of tissue
culture medium were incubated at 37°C for 4h orXENOGRAFTING AND REJECTION MECHANISM
18h together with a varying number of effector
cells in 96 microwell plates. At the end of the assay,
the supernatant of each well was collected using the
Titertek device (Skatron, Norway) and counted in a
gamma counter. The results were expressed as %
cytotoxicity.
% Cytotoxicity=
Experimental 51Cr release -
spontaneous 51Cr release
Maximal 5"Cr release-
x 100
spontaneous 51Cr release
Maximum 51Cr release was measured after addition
of 1 M HC1. Spontaneous release from labelled
YAC-1 was usually <15% after 4h and up to 40%
after 18h.
In some experiments, the results were expressed
in % inhibition of NK activity:
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Figure 1 Tumourigenicity of 4 HMCL in nude mice:
Relationship with the inoculum size. Nine to 15 nude
mice received s.c. 2 x 106 ( ), x 106 (------) and
0.5 x 106 ( cells at 3 different sites. The growth
of tumours was recorded for 7 weeks. (a) M3Dau; (b)
M4Beu; (c) M2GeB an (d) MlDo cell line.
% inhibition =
% cytotoxicity ofsplenocytes1
from treated animals
% cytotoxicity ofsplenocytes
L from control animals
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Tumourigenicity of human malignant melanoma cell
lines in nude mice
To examine heterotransplantability of HMCL
preliminary assays were undertaken using four cell
lines. Each mouse received 3 s.c. inocula of 2 x 106,
106 and 0.5 x 106 cells at 3 different sites. Figure 1
shows that when either 2 x 106 or 106 cells were
grafted, measurable tumours appeared after a one
week latency. When 0.5 x 106 cells were grafted,
tumours developed at a significant rate for the
M3Dau line but after a longer latency, while few or
no tumours developed for the three other lines.
When tumours appeared they presented as 2mm2
nodules. Thereafter, these nodules enlarged
continuously. No significant difference was
observed between the growth rates of tumours
derived from the graft of 2 x 106 or 106 cells (Figure
2). The 2 x 106 cell inoculum was chosen to further
study the growth potentiality of 6 other HMCL in
nude mice. HMCL showed a great heterogeneity in
their ability to grow in nude Illicc (Table I).
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Figure 2 Tumourigenicity of 4 HMCL in nude mice:
Kinetics of the tumour growth. The size of the local
tumour has been measured weekly for 6 weeks after
s.c. inoculation of 2 x 106 (empty column), 106 hatched
column) and 0.5 x 106 (solid column) cells. Standard
deviation of the tumour size is indicated when more
than one tumour was observed. (a) M3Dau; (b)
M4Beu; (c) M2GeB and (d) MlDO.
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Table I Heterotransplantation of 10
human malignant melanoma cell lines in
nude mice
Tumour
cell line Tumour takea
M3Dau 26/26 (100%)
M4Beu 13/15 (88%)
Mel 34 10/12 (83%)
Mel 21 8/12 (68%)
BII 6/12 (50%)
Mel 17 6/12 (50%)
Mel 14 5/12 (42%)
MlDo 12/46 (26%)
M2GeB 5/20 (25%)
Mel 8 2/12 (16%)
aTumour cells 2 x 106 were grafted s.c.
in nude mice and the tumour take was
recorded after 7 weeks.
Tumour takes varied greatly, ranging from 100% to
only 16%. From statistical studies, the 10 HMCL
could be classified as highly tumourigenic cell lines
(HTCL) with tumour takes averaging 90%, fairly
tumourigenic cell lines (FTCL) with tumour takes
averaging 50%, and poorly tumourigenic cell lines
(PTCL) with tumour takes <25%.
The inability of one PTCL (MlDo) to grow in
naive animals was further explored. A variant of
MlDo cell lines was adapted to grow in vitro in the
presence of a low amount of foetal calf serum (2%)
and it displayed the same xenografting phenotype
as the original cell line (Table II). Eight cell clones
were derived from MlDo by limiting dilution assay.
All of them displayed a similar unability to grow in
naive nude mice as their parental MlDo cell line
(Table II).
Tumourigenicity ofhuman malignant melanoma cell
lines in irradiated or silica-treated nude mice.
To analyze whether the poor ability to grow in
nude mice shown by some HMCL resulted either
from inherent characteristics of the cell lines or
from an active tumour-rejection mechanism in nude
mice, 4 cell lines (2 HTCL and 2 PTCL) were
grafted in irradiated or silica-treated mice.
Whole-body sublethal irradiation of recipients
significantly increased the tumour take of PTCL
MIDo and M2GeB (Table III). However, the
tumours grew in irradiated and in untreated
animals at the same rate (data not shown).
Moreover, the variant cell line from MlDo and the
eight clones derived from this cell line became as
tumourigenic as the parental line in irradiated
recipients (Table II).
Intraperitoneal administration of silica particles
to nude mice prior to inculation of cells from
HMCL resulted also in the increase of the tumour
take of the PTCL MlDo (Table IV). When animals
were pretreated by both irradiation and silica, no
further increase in the tumour take of low inocula
of the PTCL MIDo was observed (data not
shown).
Tumourigenicity of human malignant melanoma cell
lines admixed with BCG in nude mice.
Since xenografts of HMCL could be enhanced in
irradiated or silica-treated nude mice, attempts were
Table II Similar growth rate of MlDo cell line, of its variant and of clones
derived from it
Tumour takea
Tumour cell lines Selected
and clones culture conditions Untreated mice Irradiated mice
MlDo 10%FCSb 1/4 6/6
2% FCS 1/6 4/6
MlDoc 4 3/16 4/5
MlDoc 7 3/12 8/8
MlDoc 8 0/12 6/7
MlDoc RI limited dilution 0/8 4/5
MlDoc R2 assays 10% FCS 0/3 4/5
MIDoc R6 1/8 6/6
MlDoc R8 2/8 5/6
MlDoc RIO 0/4 5/5
aTumour cells 2 x 106 were grafted s.c. in untreated or irradiated (4.5Gy
60Co one day before heterotransplantation) nude mice and the tumour take
was recorded after 7 weeks.
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Table III Tumourigenicity of human melanoma cell lines in sub-lethally irradiated
nude mice
Number of Tumour takea
Tumour grafted cells
cell line (X 10-6) Untreated mice Irradiated miceb Yates' Chi2 test
0.5 0/15 2/15 NS
MlDo 1.0 1/15 8/15 P<0.02
2.0 4/15 14/15 P<0.05
0.5 0/12 7/12 P<0.05
M2GeB 1.0 3/12 12/12 P<0.05
2.0 3/12 9/12 P<0.05
0.5 7/9 5/9 NS
M3Dau 1.0 8/9 9/9 NS
2.0 8/9 9/9 NS
0.5 1/9 5/8 NS
M4Beu 1.0 4/9 5/8 NS
2.0 8/9 7/8 NS
aTumour cells were grafted s.c. in nude mice and the tumour take was recorded
after 7 weeks.
bNude mice were irradiated (4.5Gy) with a 60Co source one day before
heterotransplantation.
Table IV Tumourigenicity of human melanoma cell lines in silica-treated nude mice
No. of Tumour takea
Tumour grafted cells
cell lines (X 106) Untreated mice Silica-treated miceb Yate's Chi2 test
0.5 0/6 0/6
MIDo 1.0 1/10 10/15 P<0.02
2.0 2/10 11/15 P<0.01
M3Dau 0.5 6/6 6/6
aSee footnote Table III
bNude mice received i.p. 5mg of silica particles 4h before heterotransplantation
made to boost tumour-rejection mechanisms by
grafting the HTCL M3Dau in admixture with
BCG. Table V shows that in untreated nude mice,
the admixture of 100 or 500pg BCG with 0.5 x 106
melanoma cells strongly reduced the tumour take.
By contrast, the s.c. injection of BCG distal to the
0.5 x 106 cell inoculum, (on the opposite flank), did
not modify the tumour take (data not shown).
When 0.5 x 106 cells admixed with BCG were
grafted to irradiated nude mice, a sharp reduction
in tumour take similar to that obtained in untreated
mice was observed. However, when the same
number of cells admixed with 500,pg BCG were
grafted in silica-treated mice, the reduction in
tumour take was of lower magnitude.
In irradiated recipients, 500pg of BCG abolished
the tumour take from a 1 x 106 or 2 x 106 PTCL
MlDo inoculum. BCG 100pg also strongly reduced
the tumour take from an 1 x 106 cell inoculum
(Table V). In silica treated animals, 500pg BCG
similarly inhibited the Ml Do tumour take (Table V).
Role ofnatural killer (NK) activities in active
tumour-rejection mechanisms in nude mice
The above reported results indicate that the
successful growth of HMCL in nude mice might be
under the control of active rejection mechanisms.
The possible relevance of NK activities of nude
mice to such mechanisms was investigated.
Susceptibility of HMCL to NK mediated lysis
was tested in vitro. As shown in Table VI, neither
HTCL nor PTCL were killed by nude mouse
unfractionated spleen cells or non-adherent cell340 R. JACUBOVICH et al.
Table V Effect of BCG on the growth of the highly (M3Dau) or poorly (MlDo) tumourigenic cell line in
nude mice
Tumour take in recipients grafted witha
Admixture M3Dau MlDo
Pretreatment ofBCG to
ofmice Tumour inoculum 0.5b 2b b
none none 10/12 nd nd nd
100 ug 5/20 (P<0.001)c nd nd nd
500jug 1/15 (P<0.001) nd nd nd
Irradiation none 9/10 10/10 5/5 5/5
100pg 3/10 (P<0.02) 6/10 (NS) 4/12 (P<0.05) 11/12 (NS)
500pjg 3/12 (P<0.01) 9/10 (NS) 1/12 (P<0.001) 3/12 (P<0.02)
Silica none 6/6 nd 6/6 6/6
SOOpg 6/12 (NS) nd 3/12 (P<0.001) 2/12 (P<0.001)
aSee footnotes Tables III and IV.
bNumber of tumour cells ( x 10-6) used as inoculum.
cStatistical analysis between BCG-treated and the corresponding group not treated by BCG is indicated
in brackets (Yate's Chi2 test).
Table VI Resistance of melanoma cell lines to in vitro
NK-mediated lysis by spleen cells from naive nude mice
% specific lysis of5'Cr-labelled
targets at E/T=50:1
Fractionation YAC I MJDo M3Dau M4Beu
ofeffector cells 4h 18h 4h 18h 4h 18h 4h 18h
None 18.9 50.5 1.0 5.8 3.2 3.0 2.3 5.4
Nylon wool column 27 4 64.0 4.3 8.4 2.8 10.3 0.5 2.8
Non adherent cells
Nylon wool column 53 7.4 0.3 2.8 1.2 2.3 2.3 0.2
Adherent cells
Plastic non 22.3 48.5 2.3 8.0 1.5 3.4 1.2 7.3
Adherent cells
populations in 4h or 18 h assays, despite the fact
that the NK-sensitive target cell YAC-1 was readily
killed by the same effectors.
Spleen cells were obtained from nude mice 24h
after irradiation, silica pretreatment or xenografting
of HMCL and used as effectors in a cytotoxicity
assay using 5"Cr-labelled YAC-1 target cells. Table
VII shows that under these conditions no
significant difference could be seen between the NK
activities of control and treated nude mice.
On the other hand, treatment of nude mice by
i.e. injection of anti-asialo GM1 serum resulted in a
marked inhibition of the NK activity displayed by
their spleen cells (Table VII). A complete inhibition
of NK activity was obtained as early as 18h after
the antiserum injection and persisted for 2 days; an
inhibition of 30-50% of the NK activity was
observed one week after the antiserum injection and
complete recovery of the NK activity was not
reached until 2 weeks after the antiserum injection.
In spite of such a profound and long-lasting
inhibition of NK activity, anti-asialo GM1 ant-
iserum treatment of nude mice did not influence the
tumour growth of PTCL, whereas in the same
experiment silica treatment or irradiation of mice
allowed tumour growth in 100% of the animals
(Table VIII).
Effect ofMDP encapsulated in liposomes on the
tumour growth ofa HTCL
The sensitivity to silica of the active mechanism
which controlled the tumour growth of HMCL and
the boosting effect of BCG raised the possibility
that macrophages could be involved. Since MDP
encapsulated in liposomes has been shown to
locally active macrophages (Fidler et al., 1982;
Schroit et al., 1982), MDP was entrapped in multi-
lamellar liposomes made from distearoylphos-
phatidylcholine and phosphatidylserine in 7:3
molar ratio, as proposed by these authors, and
administered together with 2 x 106 M4Beu (HTCL).
Such local treatment strongly reduced the tumour
take (Table IX). As a control, a treatment with
empty liposomes was similarly performed and did
not modify the tumour take.XENOGRAFTING AND REJECTION MECHANISM 341
Table VII NK activity of nude mice following irradiation, silica,
antiasialo GM1 serum treatment or xenograft
Treatment ofmice with
Irradiation (4.5Gy 60Co)
Silica (5mg i.p.)
2 x 106 MIDoc 4 cells s.c.
2 x 106 M3Dau cells s.c.
2 x 106 M4Beu cells s.c.
2 x 106 M4Beu cells+BCG s.c.
anti-asialo GM1 serum 1/5
anti-asialo GM1 serum 1/10
anti-asialo GM1 serum 1/20
% inhibitiona oflysis
of YAC cell at E/T
Time after
treatment 50:1 25:1
24h
24h
24h
24h
24h
24h
18 h
2d
4d
7d
18h
2d
4d
7d
14d
18h
2d
4d
7d
25b
10.2b
11.6b
-9.7b
-8.1b
_3.9b
89.2
100
49
39
88.2
78
55
32
2.3
27
100
23.4
9.5
100
100
85
58
100
100
45
41
0
0
100
31
7.7
aPercentage of inhibition of lysis of 51Cr-labelled YAC target cells
by spleen cells was calculated as described in Materials and methods.
bSummary of results obtained in two experiments (cells from 3-6
animals were individually tested within each group).
Table VIII Unability of anti-asialo GM1
serum treatment to increase the tumour take of
a poorly tumourigenic cell line MIDoc 4
Tumour takes
Weeks after inoculation of
Treatment 2 x 106 MiDoc 4 cells
ofanimalsa 1 2 4 7
NRSb 1/6 1/6 1/6 1/6
Anti-asialo GM1P 2/8 2/8 2/8 2/8
Silica 3/6 4/6 6/6 6/6
Irradiation 2/6 4/6 6/6 6/6
aSee footnotes Tables III and IV.
bMice were given an i.v. injection of anti-
asialo GM1 serum (diluted 1:10) or normal
rabbit serum (diluted 1:10) 18h before cell
inoculation.
Discussion
Ability to grow in nude mice is a characteristic
shared by a large number of human tumours and
by in vitro cell lines derived from them (for review
see Hajdu & Fogh, 1978). However, the description
of some human tumours which failed to grow in
nude mice raised the possibility that xenografting
ability may reflect particular properties of the
tumour cells in an in vivo environment. In order to
define precisely the capacity of human melanoma
cell lines to grow s.c. in nude mice, we have
established standard conditions. Using a 2 x 106
tumour cell inoculum, ten HMCL exhibited a great
variability in the proportion of nude mice in which
they could grow, despite the fact that all these cell
lines had been established in vitro and that they
exhibited characteristics of malignant melanoma
cells. The tumourigenic capacity of these HMCL
was very reproducible from one experiment to
another and the HCML could therefore be
characterized as highly, fairly or poorly
tumourigenic. In addition, at least for one PCTL
which has been studied in greater detail, this
phenotype seemed to be stable even after changing
in vitro culture conditions and each cell clone
derived from it also displayed the same
tumourigenic phenotype. The definition of a
xenografting phenotype has not been previously
proposed to our knowledge mainly because the
tumour cell inoculum used in other reports varied
greatly from 106 to 20 x 106 cells (Fogh et al.,342 R. JACUBOVICH et al.
Table IX Abrogation of HTCL tumour growth after simulta-
neous local injection of MDP entrapped in liposomes
M4Beu cells 2 x 106
inoculated
together with Tumour takea Yate's Chi2 test
13/16
Empty liposomes DSPC-PS 9/15 NS
(2pM phospholipids)
MDP-liposomes DSPC-PS
(2,uM phospholipids 2/12 P<0.005
+4.3 pg MDP)
a7 weeks after inoculation in naive nu/nu mice.
1977). Other studies performed in our laboratory
have shown that the HMCL used here could also
be distinguished from each other by their karotypes
(Bertrand et al., 1984), polyamine metabolism
(Thomasset et al., 1982) and cell surface glyco-
conjugates (Berthier-Vergnes et al., submitted for
publication). Interestingly, the karotypic and
biochemical phenotypes of HCML seemed to
correlate with their xenografting phenotypes.
It has been previously reported that the
conditioning of nude mice by whole body
irradiation could allow the local growth of human
tumour cells where no such growth would occur in
naive recipients (Watanabe et al., 1978; Ohsugi et
al., 1980). It could then be questioned whether the
expression of the xenografting phenotype was
controlled by the natural defences of the nude
mouse.
Abrogation of natural immunity of nude mice by
sublethal whole body irradiation or silica was found
to allow two PTCL to grow in most animals. This
strongly suggested that an active mechanism was
likely to be involved in the expression of the
xenografting phenotype. This active mechanism was
found to be radiosensitive, destroyed by silica and
boosted by local BCG treatment. Among natural
antitumour effectors, at least three cell types could
be candidates in its expression, NK cells, NC cells
and/or activated macrophages (Herberman &
Holden, 1978).
In our model, NK cells were unlikely to be
largely involved in the antitumour growth activity
of nude recipients for the following reasons: (i) All
HMCL tested were found to be resistant to in vitro
NK cytolysis by nude spleen cells. (ii) Sublethal
whole body irradiation and silica treatment did not
affect the NK activity in the spleen of nude mice as
previously reported (Riccardi et al., 1979, see
Stutman et al., 1980 for review). (iii) Long lasting
abrogation of NK activitv in vivo by treatment with
anti-asialo-GM1 antiserum did not enhance the
growth of a poorly tumourigenic cell line.
Conflicting results were previously reported on the
role of NK cells in tumour growth control of
xenografts in nude mice. But, as underlined by
Stanbridge (1984) in a recent review, most indirect
(Minato et al., 1979; Hanna & Fidler, 1981) and
direct evidences using anti-asialo-GM1 serum
(Habu et al., 1981; Kawase et al., 1982) or fi-
oestradiol (Hanna & Schneider, 1983) which
showed a potent role of NK cells in the nude mice,
have been obtained using in vitro NK sensitive
tumour target cells. In addition, Uenishi et al.
(1983) reported that a human nasopharynx
carcinoma was insensitive in vitro to NK killing and
that the antitumour effect of mouse interferon in
nude mice was not influenced by anti-asialo GM1
serum treatment. Some involvement of NK cells in
the xenografted tumour growth cannot be
completely excluded in our experiments because: (i)
local injection of BCG in normal nude mice could
drastically increase the NK activity of peritoneal
exudated cells (Wolfe et al., 1976); (ii) human
melanoma cells lines could be killed in vitro by NK
cells after their boosting by lymphokines (Gerard et
al., 1982); (iii) regulation links have been reported
between NK cells and other antitumour effectors
such as macrophages (Pucetti et al., 1979; Reynolds
et al., 1981; Riccardi et al., 1981).
Beside NK cells, other categories of umprimed
cells such as NC cells (Stutman et al., 1980) have
been postulated to play a significant role in
resistance to "solid" allogeneic tumours. However,
they are unlikely to play a major role in the
expression of HMCL xenografting phenotype, since
as reviewed by Stutman et al. (1980), NC cells are
unaffected by sublethally whole body irradiation or
by silica treatment. In addition, an 18h cytotoxicity
assay usually allows the detection of NC activity on
NC sensitive target cells, but no significant lysis of
HMCL by nude spleen cells was ever observed in
such conditions (see Table VI).XENOGRAFTING AND REJECTION MECHANISM 343
Macrophages could be good candidates as the
active mechanism which regulated the expression of
the xenografting phenotypes of HMCL by virtue of
the observations that (i) both highly and poorly
tumourigenic melanoma cell lines could be killed in
vitro by activated macrophages from nude mice
(Benomar et al., manuscript in preparation); (ii)
though mature macrophages have been considered
to be relatively insensitive to whole body
irradiation, their precursors are likely to be
destroyed by such treatment (Nelson et al., 1978);
(iii) among wide spread effects on animals, silica
has been regularly reported to hamper macrophage
functions in vitro (Allison et al., 1966); (iv) BCG is
considered to be a local activator of macrophages
(Morahan & Kaplan, 1976); (v) MDP encapsulated
in liposomes has been clearly shown to activate
locally the macrophages and lead to in vivo tumour
cell destruction (Fidler et al., 1982; Schroit &
Fidler, 1982); and (vi) macrophages have been
reported to be unaffected by anti-asialo GM1 serum
treatment (Kawase et al., 1982). Involvement of
macrophages in the control of tumour growth in
nude mice has been previously evoked, on the basis
of silica abrogation of BCG contact suppression of
tumour growth in athymic mice (Hopper et al.,
1976). We did not observe a significant abrogation
of the BCG antitumour effect by silica; this
discrepancy can be explained by the 40-fold less
amount of silica we used in our experiments. As
more direct evidence, potent activators of
macrophages such as Bestatin (Schorlemmer et al.,
1983) and murine interferon (Uenishi et al., 1983)
were shown to drastically decrease tumour
xenografts without effect on NK activity.
As discussed above, the relative importance of
macrophages, NK and NC cells as effectors in the
nude mice are likely to vary within different
tumours, especially with regard to their in vitro
sensitivity to NK or NC killing activity.
If the macrophage is the right candidate as the
antitumour effector in nude mice against human
malanoma cell lines, it is likely that it will act after
having been activated. Therefore, the development
of a tumour might be the result of some tumour
cells escaping though no modification of the growth
kinetics was observed in irradiated or silica treated
nude mice (data not shown), and though tumour
cells recovered after growth in nude mice were
usually indistinguishable from the parental cell
population (Tveit & Pihl, 1981). As an alternative,
it can be postulated that human melanoma cell
lines may differ in their capacity to interact with
the regulatory mechanisms of macrophage
activation. The activation of macrophages by
tumour cells has been previously described (Olstad
et al., 1982), but it involved regulation by .T cells.
Therefore , it can be questioned whether the T-like
cells which have been found in nude mice
(MacDonald, 1984) may act as regulators of the
antitumour mechanism. Interestingly, it has been
reported that anti-lymphocyte serum treatment of
nude recipients could allow the growth of poorly
tumourigenic heterologous cells (Gershwin et al.,
1978; Oshugi et al., 1980). In oder to clarify the
potential role of macrophages in the antitumour
activity of nude mice, we are currently investigating
the respective capacity of HMCL to interact with
the macrophage activation process in relation to
their xenografting phenotypes.
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